Cargando…

Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients

The beneficial effects exerted by levosimendan against cardiac failure could be related to the modulation of oxidative balance. We aimed to examine the effects of levosimendan in patients with cardiogenic shock or low cardiac output on cardiac systo-diastolic function and plasma oxidants/antioxidant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grossini, Elena, Farruggio, Serena, Pierelli, Daniele, Bolzani, Virginia, Rossi, Lidia, Pollesello, Piero, Monaco, Carolina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073614/ https://www.ncbi.nlm.nih.gov/pubmed/32019057 http://dx.doi.org/10.3390/jcm9020373

Ejemplares similares

Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay
por: Grossini, Elena, et al.
Publicado: (2015)

The Adenylate Cyclase Activator Forskolin Potentiates the Positive Inotropic Effect of the Phosphodiesterase Inhibitor Milrinone But Not of the Calcium Sensitizer Levosimendan nor of Its Hemodynamically Active Metabolites: An Apparent Conundrum
por: Levijoki, Jouko, et al.
Publicado: (2022)

Levosimendan in patients with acute cardiogenic shock, not responders to conventional therapy
por: Vetrugno, L, et al.
Publicado: (2007)

Effects of levosimendan in acute heart failure, cardiogenic and septic shock
por: Alhashemi, JA, et al.
Publicado: (2008)

Hemodynamic and echographic effects of levosimendan in patients with cardiogenic shock refractory to catecholamines
por: Labbene, I, et al.
Publicado: (2006)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
por: Burkhoff, Daniel, et al.
Publicado: (2021)

Levosimendan therapy does not improve survival of post-resuscitation cardiogenic shock patients
por: Soos, P, et al.
Publicado: (2009)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Use of Levosimendan in Patients with Advanced Heart Failure: An Update
por: Masarone, Daniele, et al.
Publicado: (2022)

Haemodynamic Balance in Acute and Advanced Heart Failure: An Expert Perspective on the Role of Levosimendan
por: Agostoni, Piergiuseppe, et al.
Publicado: (2019)

Use of levosimendan in acute heart failure
por: Harjola, Veli-Pekka, et al.
Publicado: (2018)

Early Levosimendan Administration Improved Weaning Success Rate in Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock
por: Chen, Yu-Wen, et al.
Publicado: (2022)

Efficacy of levosimendan in shock
por: McLean, A, et al.
Publicado: (2004)

Effectiveness of levosimendan and role of cardiac magnetic resonance in cardiogenic shock due to COVID-19 related lymphocytic myocarditis in the course of viral sepsis
por: Mangini, Francesco, et al.
Publicado: (2023)

Renal Effects of Levosimendan: A Consensus Report
por: Yilmaz, Mehmet B., et al.
Publicado: (2013)

Rehospitalization after intermittent levosimendan treatment in advanced heart failure patients: a meta‐analysis of randomized trials
por: Silvetti, Simona, et al.
Publicado: (2017)

Monitoring of cardiac output in cardiogenic shock and low-output heart failure: LiDCO vs pulmonary artery catheter thermodilution
por: Meyer, B, et al.
Publicado: (2006)

Use of Levosimendan in Cardiac Surgery: An Update After the LEVO-CTS, CHEETAH, and LICORN Trials in the Light of Clinical Practice
por: Guarracino, Fabio, et al.
Publicado: (2018)

Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
por: Omerovic, Elmir, et al.
Publicado: (2010)

Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Early experience with levosimendan in children with low-output syndrome after cardiac surgery
por: Galas, F, et al.
Publicado: (2008)

Correction to: Can levosimendan reduce ECMO weaning failure in cardiogenic shock?: a cohort study with propensity score analysis
por: Guilherme, Enrique, et al.
Publicado: (2020)

Addition of levosimendan to overcome acute cardiogenic shock—Paving the way for later heart transplantation—A first case report
por: Flottmann, Christian, et al.
Publicado: (2020)

Synergistic effects of levosimendan and convalescence plasma as bailout strategy in acute cardiogenic shock in COVID-19: A case report
por: Fox, Henrik, et al.
Publicado: (2022)

ECMO in cardiac arrest and cardiogenic shock
por: Napp, L. C., et al.
Publicado: (2017)

Urine output for predicting in-hospital mortality of intensive care patients with cardiogenic shock
por: Hu, Tianyang, et al.
Publicado: (2023)

Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper
por: Herpain, Antoine, et al.
Publicado: (2019)

Levosimendan versus dobutamine in septic shock
por: Alhashemi, JA, et al.
Publicado: (2009)

Levosimendan as rescue therapy in low output syndrome after cardiac surgery: effects and predictors of outcome
por: Beiras-Fernandez, Andres, et al.
Publicado: (2019)

Levosimendan in cardiac surgery
por: Harjola, V, et al.
Publicado: (2004)

Levosimendan: current data, clinical use and future development
por: Nieminen, M S, et al.
Publicado: (2013)

Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
por: Guerrero Orriach, Jose Luis, et al.
Publicado: (2019)

Clinical Efficacy of Levosimendan vs Milrinone in Preventing Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery
por: Jothinath, Kaushik, et al.
Publicado: (2021)

Hemodynamic effects of levosimendan in patients with low-output heart failure
por: Gharsallah, H, et al.
Publicado: (2008)

Fulminant cardiogenic shock due to cardiac sarcoidosis
por: Genovese, Leonard, et al.
Publicado: (2021)

Cardiogenic shock /
Publicado: (2002)

Cardiogenic Shock
por: Vahdatpour, Cyrus, et al.
Publicado: (2019)

Mechanical Support in Cardiogenic Shock: The Delicate Balance Between Patient and Machine
por: Trêpa, Maria, et al.
Publicado: (2019)

Effects of Genistein on Differentiation and Viability of Human Visceral Adipocytes
por: Grossini, Elena, et al.
Publicado: (2018)

Cardiac amyloid presenting as cardiogenic shock: case series
por: Oye, Monique, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s1o5qps3nm5jmjkn971ic0m4p2